In addition to serving on the Arcturus board, Mr. Sassine serves on the boards of iCAD, Inc. (NASDAQ: ICAD), a provider of advanced image analysis, workflow solutions and radiation therapy for the early detection and treatment of cancer, and Gemphire Therapeutics, a clinical-stage biopharma company focused on therapies for the treatment of dyslipidemia. He also serves as Chairman of the Board of privately-held ComHear Inc., a digital audio software and device company.